News & Publications
Our latest scientific publications
Amelio P et al.
Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania. PLOS Neglected Tropical Diseases. Jul 2017
García-Arriaza J et al.
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates. Journal of Virology. Apr 2017
Our latest press release
27 January 2016 Launch of the EHVA consortia funded by the EU H2020 program
The European HIV Vaccine Alliance (EHVA) is a project funded by EU H2020 program. Its primary objective is to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. EuroVacc provides the support in the scientific project management.
Read press release: English / French